SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

deListed Australia

SEARCH BY NAME

BROWSE

Browse Australian delisted companies0-9A BC DE F GH IJ KL MN OP QR ST UV WX YZ
Browse terminated Australian managed funds0-9A BC DE FGH IJ KL MN OP QR ST UV WX YZ

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

SOLAGRAN LIMITED (SLA)

Delisted from ASX 31/12/2015

SHARE PRICES

Former (or subsequent) names

 FROMTO
SOLAGRAN LIMITED14/02/2003
TRAVELSHOP LIMITED29/02/200014/02/2003
PAGET MINING LIMITED11/11/199929/02/2000
PAGET MINING NL16/01/199811/11/1999
PAGET MINING LIMITED04/06/199216/01/1998
PAGET GOLD MINING COMPANY LIMITED04/06/1992

Shareholder links

Our website ranking of SLA: rating 4
(4 out of 5)
COMPANY WEBSITE:

 

REGISTRY:
Computershare, Yarra Falls, 452 Johnston Street, Abbotsford VIC 3067
Tel : +61 3 9415 4000 or 1300 850 505
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail

Company details

ISIN: w
Address: 98-106 Moray Street, South Melbourne, VIC 3205
Tel:  (03) 9820 2699 Fax: (03) 9820 3155

Date first listed: 22/12/1983
Company Secretary: Mr Justyn Stedwell
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Australian biotechnology company commercialising a series of substances known as Bioeffectives which are natural, biologically active substances that have a wide range of beneficial applications in the prevention of disease, treatment of illness and promo
delisted from the close of trading on Thursday, 31 December 2015, pursuant to Listing rule 17.12 and Guidance Note 3331/12/2015
we understand that it is ASX policy to automatically remove from the official list any entity whose securities have been suspended from trading for a continuous period of 3 years31/12/2015
Solagran Limited (Company) has received notification from ASX that the Company will be removed from the official list of the ASX with effect from 4 January 2016.Solagran Ltd. intends to re-apply for admission to ASX in the first quarter of 2016.31/12/2015
The company issues its corporate governance statement.17/12/2015
The company lodges its 2015 annual report.15/12/2015
The company lodges its 2014 annual report.15/12/2015
The company lodges its 2013 annual report.15/12/2015
The company lodges its 2012 annual report.15/12/2015
The company announces that it has secured a capital investment of $3,000,000 from sophisticated investors. The funding is in the form of a loan and converting note arrangement with 100,000,000 fully paid ordinary shares at AUD $0.03 per share to be issued following approval by shareholders. Solagran further announces that the company's annual reports and annual accounts for the financial years 2012 to 2015 are currently being finalised by auditors and will be filed imminently.15/12/2015
The company announces that it has secured a capital investment of $3,000,000 from sophisticated investors. The funding is in the form of a loan and converting note arrangement with 100,000,000 fully paid ordinary shares at AUD $0.03 per share to be issued following approval by shareholders. Solagran further announces that the company's annual reports and annual accounts for the financial years 2012 to 2015 are currently being finalised by auditors and will be filed imminently.15/12/2015
The following entity (Solagran Limited) has not paid their annual listing fees in respect of the year ending 30 June 2016 but the securities are already suspended from official quotation. Under listing rule 17.15, any entity that has not paid its annual listing fees as required by listing rule 16.5 by 5.00 pm AEST on Monday 31 August 2015 will be removed from the official list with effect from the close of trading on Monday 31 August 2015 25/08/2015
Solagran Ltd (ASX: SLA) announces that a further key patent recently issued in the United States. This US patent protects medicinal agents, including the Company's Ropren product and other prenol formulations, used for treating certain important disease types caused by excessive activity of monoamine oxidase enzymes15/04/2015
Solagran Limited (ASX: SLA) announces that a key patent protecting the Company's core production technology for the manufacture of Bioeffectives®, including polyprenols / "Bioeffective R" (the major component of Ropren®), has issued in the United States18/03/2015
announce the appointment of Lodge Partners Pty Ltd as its nominated adviser and broker. 03/04/2014
suspended following failure to lodge financial reports01/03/2012
reinstated to quotation03/03/2011
suspended from quotation following failure to lodge its half yearly financial report01/03/2011
reinstated to quotation12/08/2003
company advises that the placement offer as detailed in the Supplementary Prospectus is closed24/07/2003
the company failed to lodge its half yearly financial statements on time and ASIC has taken action to prevent the company from using the limited disclosure regime when raising money17/07/2003
shares suspended from quotation on 14 January 2003 while the company was called Travelshop Limited - company announcements are available at www.asx.com.au under the present name Solagran Limited31/03/2003
name changed from Travelshop Limited14/02/2003

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)

     

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Ian NisbetNon Exec Chairman24/10/2014
    Darren SchliebsCEO25/11/2013
    Vagif SoultanovNon Exec Director29/08/2003
    Alexander KurganovDirector06/02/2009

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Andi SolaimanNon Exec Director27/07/200923/09/2015
    David CrollCFO28/07/201007/09/2012

    Date of first appointment, title may have changed.